NEWS: We are excited to announce that the U.S. Food and Drug Administration has approved our flagship therapy for patients with previously treated advanced #NeuroendocrineTumors (NET). Read more about this new treatment option now available for patients: https://bit.ly/42rjTWb.?
关于我们
Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. Cancer is our cause. Make it yours, too. Please see our Community Guidelines: bit.ly/2XXw9w3 For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
- 网站
-
https://www.exelixis.com
Exelixis的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Alameda，California
- 类型
- 上市公司
- 创立
- 1994
地点
Exelixis员工
动态
-
Preclinical data from four of our pipeline molecules to be presented for the first time at #AACR25. Read more: bit.ly/3QKqF3P.
-
-
In honor of #KidneyCancerAwarenessMonth, we’re proud to highlight our?advocacy?partner, Kidney Cancer Association. ? They provide supportive?tools to help guide patients and caregivers through the challenges of a kidney cancer diagnosis. Learn more about how you can turn awareness into action!? ?
During #KidneyCancerAwarenessMonth, the KCA encourages everyone to #OrangeUp and honor those impacted by #kidneycancer. ?? In the US, over 600,000 people live with kidney cancer and thousands of new cases will be diagnosed this year. Thanks to breakthrough treatments & research, hope is stronger than ever! In March, we celebrate the collective efforts of patients, families, healthcare professionals, and anyone who advocates to move the needle in kidney cancer. https://lnkd.in/eTJ3K5Um
-
-
Reflecting on a month of giving back! Our incredible team volunteered their time and skills to make a positive impact in our community, including… ?Made bracelets with Cancer Support Community San Francisco Bay Area for cancer patients in honor of World Cancer Day ?Wrote greeting cards for those living with cancer in collaboration with American Cancer Society hope lodge in Philadelphia ?Helped to sort fruits at the Alameda County Community Food Bank ?Walked dogs and helped organize the Friends of the Alameda Animal Shelter (FAAS) pet food pantry for those in need of cat and dog food
-
David Harris, a valued member of the Exelixis team, shares his personal journey with kidney cancer and the importance of early detection. ? This #WorldKidneyDay, we encourage everyone to prioritize kidney health. ? #AreYourKidneysOK
-
We’re proud to partner with KidneyCAN, a patient-created and patient-driven organization on a mission to accelerate cures for kidney cancer. Join us in raising awareness and driving change for those affected by kidney cancer. Learn more about their resources: https://bit.ly/3XHdHrc. #KidneyCancerAwarenessMonth
-
Inspiring the next generation! We had an incredible time hosting high school students from Alameda and Oakland for our career exploration event. From hands on activities to insightful discussions with our team, we hope to spark curiosity and passion for science in these future innovators! #FutureLeaders #WhyWeExel
-
We’re partnering with The Healing NET Foundation to stand with the neuroendocrine tumor (NET) community and highlight the need for more comprehensive care for rare cancers. ? Together, we’re committed to addressing the community’s unmet needs, advancing research and treatments and bringing hope to those affected. ? Learn more about their resources: https://bit.ly/4h4hNAw. #RareDiseaseDay
-